Global Codeine Market Growth 2023-2029

Global Codeine Market Growth 2023-2029

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
LPI (LP Information)' newest research report, the “Codeine Industry Forecast” looks at past sales and reviews total world Codeine sales in 2022, providing a comprehensive analysis by region and market sector of projected Codeine sales for 2023 through 2029. With Codeine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Codeine industry.
This Insight Report provides a comprehensive analysis of the global Codeine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Codeine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Codeine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Codeine and breaks down the forecast by ingredient, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Codeine.
The global Codeine market size is projected to grow from US$ 267 million in 2022 to US$ 177 million in 2029; it is expected to grow at a CAGR of 177 from 2023 to 2029.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
This report presents a comprehensive overview, market shares, and growth opportunities of Codeine market by product ingredient, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by ingredient
Single-ingredient Codeine
Multi-ingredient Medications
Segmentation by application
Narcotic Analgesic
Antitussive
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Key Questions Addressed in this Report
What is the 10-year outlook for the global Codeine market?
What factors are driving Codeine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Codeine market opportunities vary by end market size?
How does Codeine break out ingredient, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.